Quantification and molecular characterization of regulatory T cells in connective tissue diseases

Autoimmunity

Volumn 42, Issue 1, 2009, Pages 41-49

  Banica, Leontina ^a   Besliu, Alina ^a   Pistol, Gina ^a   Stavaru, Crina ^b   Ionescu, Ruxandra ^c   Forsea, Ana Maria ^c   Tanaseanu, Cristina ^d   Dumitrache, Sergiu ^e   Otelea, Dan ^f   Tamsulea, Isabela ^f   Tanaseanu, Stefanita ^g   Chitonu, Cristina ^a   Paraschiv, Simona ^f   Balteanu, Monica ^a   Stefanescu, Maria ^a   Matache, Cristiana ^a  

^a CANTACUZINO INSTITUTE   (Romania)

^b Ion Cantacuzino National Institute of Microbiology   (Romania)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d Sf Pantelimon Clin Emergency Hosp   (Romania)

^e Carol Davila Clinical Hospital for Nephrology   (Romania)

^f Matei Bals National Institute of Infectious Diseases   (Romania)

^g Carol Davila School of Medicine   (Romania)

Author keywords

Autoantibodies; Connective tissue diseases; Foxp3; Phenotypical markers; Regulatory T cells

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; GLUCOCORTICOID; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; MEPREDNISONE; MESSENGER RNA; METHOTREXATE; PENICILLAMINE; PREDNISONE; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; BLOOD ANALYSIS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MARKER GENE; MEMORY T LYMPHOCYTE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 58149485202     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930802282651     Document Type: Article

References (56)

1. Stockinger, B. (1999) T lymphocyte tolerance: From thymic deletion to peripheral control mechanisms. Adv Immunol, 71, pp. 229-265.
2. Dieckmann, D., Plottner, H., Berchtold, S., Berger, T. and Schuler, G. (2001) Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med, 193, pp. 1303-1310.
3. Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J. and Enk, AH (2001) Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med, 193, pp. 1285-1294.
4. Ng, WF, Duggan, PJ, Ponchel, F., Matarese, G., Lombardi, G., Edwards, AD, Isaacs, JD and Lechler, RI (2001) Human CD4(+)CD25(+) cells: A naturally occurring population of regulatory T cells. Blood 98, pp. 2736-2744.
5. Godfrrey, WR, Ge, YG, Sponden, DJ, Levine, BL, June, HCH, Blazar, BR and Porter, SB (2004) In vitro-expanded human CD4+CD25high T regulatory cells. Blood, 104, pp. 453-461.
6. Sakaguchi, S., Masahiro, O., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z., Shimizu, J., Takahashi, T. and Nomura, T. (2006) Foxp3+ CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev, 212, pp. 8-27.
7. Sansom, DM and Walker, LS (2006) The role of CD28 and cytotoxic T-lymphocytes antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol Rev, 212, pp. 131-148.
8. Ermann, J. and Fathman, GC (2003) Costimulatory signals controlling regulatory T cells. Proc Natl Acad Sci USA, 100, pp. 15292-15293.
9. McHugh, RS, Whitters, MJ, Piccirillo, CA, Young, DA, Shevach, EM, Collins, M. and Byrne, MC (2002) CD4(+)CD25(+) immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity, 16, pp. 311-323.
10. Shevach, EM and Stephens, GL (2006) The GITR-GITRL interaction: Co-stimulation or contrasuppression of regulatory activity?. Nat Rev Immunol, 6, pp. 613-618.
11. Akbar, AN, Taams, LS, Salmonz, M. and Vukmanovic-Stejic, M. (2003) The peripheral generation of CD4+CD25+ regulatory T cells. Immunology, 109, pp. 319-325.
12. Tang, Q. and Bluestone, JA (2006) Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev, 212, pp. 217-237.
13. Dejaco, C., Duftner, C., Grubeck-Loebenstein, B. and Schirmer, M. (2005) Imbalance of regulatory T cells in human autoimmune diseases. Immunology, 117, pp. 289-300.
14. Lindley, S., Dayan, CM, Bishop, A., Roep, BO, Peakman, M. and Tree, TI (2005) Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes, 54, pp. 92-99.
15. Viglietta, V., Baecher-Allan, C., Weiner, HL and Hafler, DA (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med, 199, pp. 971-979.
16. Ehrenstein, MR, Evans, JG, Singh, A., Moore, S., Warnes, G., Isenberg, DA and Mauri, C. (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med, 200, pp. 277-285.
17. Kriegel, MA, Lohmann, T., Gabler, C., Blank, N., Kalden, JR and Lorenz, HM (2004) Defective suppressor function of human CD4+CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med, 199, pp. 1285-1291.
18. Sugiyama, H., Gyulai, R., Toichi, E., Garaczi, E., Shimada, S., Stevens, SR, McCormick, TS and Cooper, KD (2005) Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: Mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol, 174, pp. 164-173.
19. Tan, EM, Cohen, AS, Fries, JF, Masi, AT, McShane, DJ, Rothfield, NF, Schaller, JG, Talal, N. and Winchester, RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 25, pp. 1271-1277.
20. LeRoy, EC, Black, C., Fleischmajer, R., Jablonska, S., Krieg, T., Medsger Jr., TA, Rowell, N. and Wollheim, F. (1988) Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol, 15, pp. 202-205.
21. Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, HM, Alexander, EL, Carsons, SE, Daniels, TE, Fox, PC, Fox, RI, Kassan, SS, Pillemer, SR, Talal, N., Weisman, MH and The European Study Group on Classification Criteria for Sjogren's Syndrome (2002) Classification criteria for Sjogren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis, 61, pp. 554-558.
22. Bohan, A. and Peter, JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med, 292, pp. 344-347.
23. Stassen, M., Fondel, S., Bopp, T., Richter, C., Muller, C., Kubach, J., Becker, C., Knop, J., Enk, AH, Schmitt, S., Schmitt, E. and Jonuleit, H. (2004) Human CD25+ regulatory T cells: Two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+T helper cells. Eur J Immunol, 34, pp. 1303-1311.
24. Matache, C., Onu, A., Stefanescu, M., Tanaseanu, S., Dragomir, C., Dolganiuc, A. and Szegli, G. (2001) Dysregulation of p56lck kinase in patients with systemic lupus erythematosus. Autoimmunity, 34, pp. 27-38.
25. Baecher-Allan, C., Brown, JA, Freeman, GJ and Hafler, DA (2001) CD4+ CD25high regulatory cells in human peripheral blood. J Immunol, 167, pp. 1245-1253.
26. Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, TW and Sakaguchi, S. (2000) Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med, 192, pp. 303-310.
27. Wing, K., Ekmark, A., Karlsson, H., Rudin, A. and Suri-Payer, E. (2002) Characterization of human CD25+CD4+T cells in thymus, cord and adult blood. Immunology, 106, pp. 190-199.
28. Fontenot, JD, Gavin, MA and Rudensky, AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol, 4, pp. 330-336.
29. Khattri, R., Cox, T., Yasayko, S-A and Ramsdell, F. (2003) An essential role for Scurfin in CD4+CD25+T regulatory cells. Natl Immunol, 4, pp. 337-342.
30. Sakaguchi, S. (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol, 22, pp. 531-562.
31. Lim, HW, Hillsamer, P., Banham, AH and Kim, CH (2005) Cutting edge: Direct suppression of B cells by CD4+CD25+ regulatory T cells. J Immunol, 175, pp. 4180-4183.
32. Bluestone, JA and Tang, Q. (2005) How do CD4+CD25+ regulatory T cells control autoimmunity?. Curr Opin Immunol, 17, pp. 638-642.
33. Ni Choileain, N and Redmond, HP (2006) Regulatory T-cells and autoimmunity. J Surg Res, 130, pp. 124-135.
34. Crispin, JC, Martinez, A. and Alcocer-Varela, J. (2003) Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun, 21, pp. 273-276.
35. Liu, MF, Wang, CR, Fung, LL and Wu, CR (2004) Decreased CD4+CD25+T cells in perpheral blood of patients with systemic lupus erythematosus. Scand J Immunol, 59, pp. 198-202.
36. Lee, JH, Wang, LC, Lin, YT, Yang, YH, Lin, DT and Chiang, BL (2006) Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology, 117, pp. 280-286.
37. Wei, HG, Cai, B., Wang, LL, Li, J. and Feng, WH (2007) Analysis of Foxp3(+) CD4(+) CD25(+) regulatory cells in peripheral blood of patients with SLE [abstract]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 23, pp. 432-435.
38. Lyssuk, EY, Torgashina, AV, Soloviev, SK, Nassonov, EL and Bykovskaia, SN (2007) Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol, 601, pp. 113-119.
39. Bonelli, M., von Dalwigk, K., Savitskaya, A., Smolen, JS and Scheinecker, C. (2008) Foxp3 expression in CD4+T cells of patients with systemic lupus erythematosus (SLE): A comparative phenotypic analysis. Ann Rheum Dis, 67, pp. 664-671.
40. Barath, S., Soltesz, P., Kiss, E., Aleksza, M., Zeher, M., Szegedi, G. and Sipka, S. (2007) The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4(+)CD25(high) FoxP3(+) regulatory T cells during repeated plasmapheresis treatments of patients. Autoimmunity, 40, pp. 521-528.
41. Suarez, A., Lopez, P., Gomez, J. and Gutierrez, C. (2006) Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann Rheum Dis, 65, pp. 1512-1517.
42. Alvarado-Sanchez, B., Hernandez-Castro, B., Portales-Perez, D., Baranda, L., Layseca-Espinosa, E., Abud-Mendoza, C., Cubillas-Tejeda, AC and Gonzalez-Amaro, R. (2006) Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun, 27, pp. 110-118.
43. Miyara, M., Amoura, Z., Parizot, C., Badoual, C., Dorgham, K., Trad, S., Nochy, D., Debre, P., Piette, JC and Gorochov, G. (2005) Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol, 175, pp. 8392-8400.
44. Valencia, X., Yarboro, C., Illei, G. and Lipsky, PE (2007) Deficient CD4+ CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol, 178, pp. 2579-2588.
45. Gottenberg, JE, Lavie, F., Abbed, K., Gasnault, J., Le Nevot, E, Delfraissy, JF, Taoufik, Y. and Mariette, X. (2005) CD4CD25high regulatory T cells are not impaired in patients with primary Sjogren's syndrome. J Autoimmun, 24, pp. 235-242.
46. Minami, R., Sakai, K., Miyamura, T., Yamamoto, M. and Suematsu, E. (2006) The role of CD4+CD25+ regulatory T cells in patients with Rheumatoid Arthritis [abstract]. Nihon Rinsho Meneki Gakkai Kaishi, 29, pp. 37-42.
47. Nocentini, G., Ronchetti, S., Cuzzocrea, S. and Riccardi, C. (2007) GITR/ GITRL: More than an effector T cell co-stimulatory system. Eur J Immunol, 37, pp. 1165-1169.
48. Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y. and Sakaguchi, S. (2002) Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol, 3, pp. 135-142.
49. Eggena, MP, Walker, LS, Nagabhushanam, V., Barron, L., Chodos, A. and Abbas, AK (2004) Cooperative roles of CTLA-4 and regulatory T cells in tolerance to an islet cell antigen. J Exp Med, 199, pp. 1725-1730.
50. Hori, S., Nomura, T. and Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science, 299, pp. 1057-1061.
51. Karagiannidis, C., Akdis, M., Holopainen, P., Woolley, NJ, Hense, G., Ruckert, B., Mantel, P-Y, Menz, G., Akdis, CA, Blaser, K. and Schmidt-Weber, CB (2004) Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol, 114, pp. 1425-1433.
52. Sailler, L., Puissant, B., Meliani, P., Castex, JO, Saivin, S., Adoue, D., Fournie, EB, Arlet, P., Montastruc, JL, Lapeyre-Mestre, M., Pourrat, J. and Blancher, A. (2007) Blood concentrations of hydroxychloroquine and its desethyl derivative correlate negatively with the percentage of CD45RO+ cells among CD4+ lymphocytes in hydroxychloroquine-treated lupus patients. Ann N Y Acad Sci, 1108, pp. 41-50.
53. Stock, P., Akbari, O., DeKruyff, RH and Umetsu, DT (2005) Respiratory tolerance is inhibited by the administration of corticosteroids. J Immunol, 175, pp. 7380-7387.
54. Bamberger, CM, Else, T., Bamberger, AM, Beil, FU and Schulte, HM (1997) Regulation of the human interleukin-2 gene by the alpha and beta isoforms of the glucocorticoid receptor. Mol Cell Endocrinol, 136, pp. 23-28.
55. Demirkiran, A., Kok, A., Kwekkeboom, J., Kusters, JG, Metselaar, HJ, Tilanus, HW and van der Laan, LJW (2006) Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transplant, 12, pp. 277-284.
56. Nelson, BH (2004) IL-2, regulatory T cells, and tolerance. J Immunol, 172, pp. 3983-3988.